Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Quantum Biopharma Ltd. (QNTM : NSDQ)

• Company Description    Quantum BioPharma is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Quantum BioPharma, formerly known as FSD Pharma Inc., is based in Toronto, Ontario. Number of Employees: 7

• Price / Volume Information    Yesterday's Closing Price: $18.92 Daily Weekly Monthly 20 Day Moving Average: 375,668 shares Shares Outstanding: 2.91 (millions) Market Capitalization: $55.01 (millions) Beta: 0.67 52 Week High: $38.25 52 Week Low: $2.70 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -0.42% -4.15% 12 Week 200.32% 152.61% Year To Date 414.13% 381.48%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 55 University Avenue Suite 1003 - Toronto,A6 M5J 2H7 CAN ph: 416-854-8884 fax: - ir@quantumbiopharma.com http://www.quantumbiopharma.com

• General Corporate Information    Officers Zeeshan Saeed - CEO; President; Co-Executive Chairman and Director Anthony Durkacz - Co-Executive Chairman and Director Donal Carroll - Chief Financial Officer Dr. Lakshmi P. Kotra - Director Adnan Bashir - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 74764Y205 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/13/25 Share - Related Items Shares Outstanding: 2.91 Most Recent Split Date: 8.00 (0.02:1) Beta: 0.67 Market Capitalization: $55.01 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.20 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.41 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/13/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 11.31 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 56.57% vs. Previous Quarter: 51.21% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/25 - - 03/31/25 - -155.20 12/31/24 - -121.98 ROA 06/30/25 - - 03/31/25 - -94.90 12/31/24 - -86.70 Current Ratio 06/30/25 - - 03/31/25 - 0.96 12/31/24 - 1.80 Quick Ratio 06/30/25 - - 03/31/25 - 0.95 12/31/24 - 1.79 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Book Value 06/30/25 - - 03/31/25 - 1.67 12/31/24 - 4.54 Inventory Turnover 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Equity 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00

Powered by Zacks Investment Research ©